People · Operator

David C. Vaughan

Named in public records as an officer, director or promoter · active 2026–2026 · Biotechnology

1
Companies
1
Filings
$2.1M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Jupiter Biomedical Research, Inc.BiotechnologyPre-Seed$2.1M$844K2026
Operator network

David C. Vaughan at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Charles H. Burns · 1 companies · 1 sharedCharles H. BurnsFrank Gerardi · 1 companies · 1 sharedFrank GerardiFrank H. Gerardi · 1 companies · 1 sharedFrank H. GerardiJohn C. Fanaras · 1 companies · 1 sharedJohn C. FanarasJohn H. Fanaras · 1 companies · 1 sharedJohn H. FanarasKingsley C. Ward · 1 companies · 1 sharedKingsley C. WardRichard H. Tambone · 1 companies · 1 sharedRichard H. TamboneRichard P. Tambone · 1 companies · 1 sharedRichard P. TamboneRobert C. Hackney · 1 companies · 1 sharedRobert C. HackneyTipton C. Shonkwiler · 1 companies · 1 sharedTipton C. Shonkwi…Viviam G. Tucker · 1 companies · 1 sharedViviam G. TuckerVivian G. Tucker · 1 companies · 1 sharedVivian G. TuckerWilliam G. Tucker · 1 companies · 1 sharedWilliam G. TuckerJupiter Biomedical Research, Inc. · $2.1M raisedJupiter Biomedical Re…David C. VaughanDV
David C. Vaughan Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside David C. Vaughan on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Frank Gerardi11
John C. Fanaras11
Tipton C. Shonkwiler11
Robert C. Hackney11
Richard P. Tambone11
William G. Tucker11
Kingsley C. Ward11
John H. Fanaras11
Charles H. Burns11
Frank H. Gerardi11
Richard H. Tambone11
Vivian G. Tucker11
Viviam G. Tucker11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.